Archive - August 2023
Chemistree Solutions: Territory Manager – Animal Health
Chemistree Solutions: Territory Manager – Animal Health
BlueRock's Phase I study with bemdaneprocel in patients with Parkinson's disease meets primary endpoint
Galderma: Außendienstmitarbeiter OTC (m/w/d)
Drug that targets scar-like tissue in tumours shows promise for aggressive pancreatic cancer
U.S. FDA Approves Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
Novartis completes acquisition of Chinook Therapeutics
New 'promising medicines' fund may incentivise commercialisation of high price drugs with weak evidence on clinical benefits